Cargando…
VAT: a precise mechanism to identify drug-food companies
The impact of drug-foods (tobacco and cane sugar, cocoa and caffeine) and the consequences of their production on the health of both public and planet are wide ranging and increasing from obesity to pressure on water supply. The world’s food system is dominated by a small number of global corporatio...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273360/ https://www.ncbi.nlm.nih.gov/pubmed/35285887 http://dx.doi.org/10.1093/pubmed/fdac030 |
_version_ | 1785059668354138112 |
---|---|
author | Cooper, Kate Parle, James Middleton, John D |
author_facet | Cooper, Kate Parle, James Middleton, John D |
author_sort | Cooper, Kate |
collection | PubMed |
description | The impact of drug-foods (tobacco and cane sugar, cocoa and caffeine) and the consequences of their production on the health of both public and planet are wide ranging and increasing from obesity to pressure on water supply. The world’s food system is dominated by a small number of global corporations making and promoting drug-foods in myriad forms. The use of sugar-substitute non-sugar sweeteners, and their design of products, are specifically formulated to be ‘moreish’, to stimulate pleasure responses above and beyond the natural pleasure of eating. In the UK we can identify these foods, and the corporations that make them, since Value Added Tax (VAT) is applied. We suggest that, for food and drink upon which UK VAT is levied, advertising and product placement should be prohibited and controls put on branding and packaging. We further suggest action is taken to: (i) restrain the activities of the companies making these products, (ii) prohibit their sponsorship and/or partnership with government bodies such as schools and NHS, (iii) ensure these corporations pay the full fiscal and environmental costs of drug-foods. Our urgent challenge is to act against the sociopathic power of such corporations, for the public health and that of the planet. |
format | Online Article Text |
id | pubmed-10273360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102733602023-06-17 VAT: a precise mechanism to identify drug-food companies Cooper, Kate Parle, James Middleton, John D J Public Health (Oxf) Original Article The impact of drug-foods (tobacco and cane sugar, cocoa and caffeine) and the consequences of their production on the health of both public and planet are wide ranging and increasing from obesity to pressure on water supply. The world’s food system is dominated by a small number of global corporations making and promoting drug-foods in myriad forms. The use of sugar-substitute non-sugar sweeteners, and their design of products, are specifically formulated to be ‘moreish’, to stimulate pleasure responses above and beyond the natural pleasure of eating. In the UK we can identify these foods, and the corporations that make them, since Value Added Tax (VAT) is applied. We suggest that, for food and drink upon which UK VAT is levied, advertising and product placement should be prohibited and controls put on branding and packaging. We further suggest action is taken to: (i) restrain the activities of the companies making these products, (ii) prohibit their sponsorship and/or partnership with government bodies such as schools and NHS, (iii) ensure these corporations pay the full fiscal and environmental costs of drug-foods. Our urgent challenge is to act against the sociopathic power of such corporations, for the public health and that of the planet. Oxford University Press 2022-03-14 /pmc/articles/PMC10273360/ /pubmed/35285887 http://dx.doi.org/10.1093/pubmed/fdac030 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Article Cooper, Kate Parle, James Middleton, John D VAT: a precise mechanism to identify drug-food companies |
title | VAT: a precise mechanism to identify drug-food companies |
title_full | VAT: a precise mechanism to identify drug-food companies |
title_fullStr | VAT: a precise mechanism to identify drug-food companies |
title_full_unstemmed | VAT: a precise mechanism to identify drug-food companies |
title_short | VAT: a precise mechanism to identify drug-food companies |
title_sort | vat: a precise mechanism to identify drug-food companies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10273360/ https://www.ncbi.nlm.nih.gov/pubmed/35285887 http://dx.doi.org/10.1093/pubmed/fdac030 |
work_keys_str_mv | AT cooperkate vataprecisemechanismtoidentifydrugfoodcompanies AT parlejames vataprecisemechanismtoidentifydrugfoodcompanies AT middletonjohnd vataprecisemechanismtoidentifydrugfoodcompanies |